These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34533633)

  • 21. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.
    Muto Y; Sato S; Watanabe A; Moriwaki H; Suzuki K; Kato A; Kato M; Nakamura T; Higuchi K; Nishiguchi S; Kumada H;
    Clin Gastroenterol Hepatol; 2005 Jul; 3(7):705-13. PubMed ID: 16206505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis.
    Saeki C; Takano K; Oikawa T; Aoki Y; Kanai T; Takakura K; Nakano M; Torisu Y; Sasaki N; Abo M; Matsuura T; Tsubota A; Saruta M
    BMC Musculoskelet Disord; 2019 Dec; 20(1):615. PubMed ID: 31878909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Branched-chain amino acids supplementation has beneficial effects on the progression of liver cirrhosis: A meta-analysis.
    Du JY; Shu L; Zhou YT; Zhang L
    World J Clin Cases; 2022 Oct; 10(30):10984-10996. PubMed ID: 36338230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sarcopenia associates with increased risk of hepatocellular carcinoma among male patients with cirrhosis.
    Feng Z; Zhao H; Jiang Y; He Z; Sun X; Rong P; Wang W
    Clin Nutr; 2020 Oct; 39(10):3132-3139. PubMed ID: 32057535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based clinical practice guidelines for liver cirrhosis 2015.
    Fukui H; Saito H; Ueno Y; Uto H; Obara K; Sakaida I; Shibuya A; Seike M; Nagoshi S; Segawa M; Tsubouchi H; Moriwaki H; Kato A; Hashimoto E; Michitaka K; Murawaki T; Sugano K; Watanabe M; Shimosegawa T
    J Gastroenterol; 2016 Jul; 51(7):629-50. PubMed ID: 27246107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The nutritional state and treatment in cirrhotic patients].
    Shiraki M; Hanai T; Shimizu M
    Nihon Shokakibyo Gakkai Zasshi; 2017; 114(1):20-26. PubMed ID: 28070091
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis.
    Hanai T; Shiraki M; Watanabe S; Imai K; Suetsugu A; Takai K; Moriwaki H; Shimizu M
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1809-1816. PubMed ID: 30779213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study.
    Park JG; Tak WY; Park SY; Kweon YO; Chung WJ; Jang BK; Bae SH; Lee HJ; Jang JY; Suk KT; Oh MJ; Heo J; Woo HY; Jang SY; Lee YR; Lee JS; Kim DY; Kim SH; Suh JI; Kim IH; Kang MK; Lee WK
    Nutrients; 2020 May; 12(5):. PubMed ID: 32429077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-Generated Subjective Global Assessment and Computed Tomography in the assessment of malnutrition and sarcopenia in patients with cirrhosis: Is there any association?
    Zambrano DN; Xiao J; Prado CM; Gonzalez MC
    Clin Nutr; 2020 May; 39(5):1535-1540. PubMed ID: 31307841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective study for an independent predictor of prognosis in liver cirrhosis based on the new sarcopenia criteria produced by the Japan Society of Hepatology.
    Kikuchi N; Uojima H; Hidaka H; Iwasaki S; Wada N; Kubota K; Nakazawa T; Shibuya A; Fujikawa T; Kako M; Sato T; Koizumi W
    Hepatol Res; 2021 Sep; 51(9):968-978. PubMed ID: 34269502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malnourished cirrhotic patient: what should we do?
    Sciarrone SS; Zanetto A; Russo FP; Germani G; Gambato M; Battistella S; Pellone M; Shalaby S; Burra P; Senzolo M
    Minerva Gastroenterol (Torino); 2021 Mar; 67(1):11-22. PubMed ID: 33784807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C.
    Kalidindi Y; Jung J; Feldman R; Riley T
    JAMA Netw Open; 2020 Jul; 3(7):e2011055. PubMed ID: 32692371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase Angle Is an Independent Predictor of 6-Month Mortality in Patients With Decompensated Cirrhosis: A Prospective Cohort Study.
    Saueressig C; Glasenapp JH; Luft VC; Alves FD; Ferreira PK; Hammes TO; Dall'Alba V
    Nutr Clin Pract; 2020 Dec; 35(6):1061-1069. PubMed ID: 33058222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma.
    Meza-Junco J; Montano-Loza AJ; Baracos VE; Prado CM; Bain VG; Beaumont C; Esfandiari N; Lieffers JR; Sawyer MB
    J Clin Gastroenterol; 2013; 47(10):861-70. PubMed ID: 23751844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the branched-chain amino acid to tyrosine ratio and branched-chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1412-9. PubMed ID: 25799910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutrition and exercise in the management of liver cirrhosis.
    Toshikuni N; Arisawa T; Tsutsumi M
    World J Gastroenterol; 2014 Jun; 20(23):7286-97. PubMed ID: 24966599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE).
    Guglielmi FW; Panella C; Buda A; Budillon G; Caregaro L; Clerici C; Conte D; Federico A; Gasbarrini G; Guglielmi A; Loguercio C; Losco A; Martines D; Mazzuoli S; Merli M; Mingrone G; Morelli A; Nardone G; Zoli G; Francavilla A
    Dig Liver Dis; 2005 Sep; 37(9):681-8. PubMed ID: 15978878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nutrition in Liver Cirrhosis: Clinical Practice Recommendations].
    Plauth M
    Dtsch Med Wochenschr; 2019 Sep; 144(18):1267-1274. PubMed ID: 31514217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Royal Free Hospital-Nutritional Prioritizing Tool improves the prediction of malnutrition risk outcomes in liver cirrhosis patients compared with Nutritional Risk Screening 2002.
    Wu Y; Zhu Y; Feng Y; Wang R; Yao N; Zhang M; Liu X; Liu H; Shi L; Zhu L; Yang N; Chen H; Liu J; Zhao Y; Yang Y
    Br J Nutr; 2020 Dec; 124(12):1293-1302. PubMed ID: 32600494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nutrition in cirrhosis and chronic liver disease.
    Juakiem W; Torres DM; Harrison SA
    Clin Liver Dis; 2014 Feb; 18(1):179-90. PubMed ID: 24274873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.